欧洲组织再生市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲组织再生市场 – 行业趋势和 2029 年预测

  • Healthcare
  • Upcoming Report
  • Nov 2024
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Europe Tissue Regeneration Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2025 –2032
Diagram Market Size (Base Year)
USD 19.48 Billion
Diagram Market Size (Forecast Year)
USD 57.56 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>欧洲组织再生市场,按技术(细胞疗法、干细胞疗法、干细胞来源、组织血管化、细胞培养等)、原材料(合成、转基因、生物)、应用(心血管、肿瘤学、皮肤病学、骨科、神经病学、眼科等)、最终用户(医院和诊断中心、制药和生物技术公司、合同研究组织等)划分 – 行业趋势和预测至 2029 年

欧洲组织再生市场

市场分析和规模

组织再生是指再生或替换患病或受损组织以进行修复或修补的过程。先天性疾病、异常和疾病引起的组织损伤都增加了组织再生的需求。组织工程是一种保存、恢复和改善受损组织功能的技术。通过重建受损器官(例如肾脏),组织再生过程可以延长患者的预期寿命。再生医学可以结束目前的器官捐赠者短缺;例如,组织工程皮肤有利于皮肤替换、烧伤、伤口和影响腿部和足部的溃疡。

Data Bridge Market Research 分析称,2021 年组织再生市场规模为 129.8 亿美元,到 2029 年将飙升至 381.1 亿美元,预计在 2022 年至 2029 年的预测期内复合年增长率为 14.5%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

市场定义

恢复或更换受损或患病的组织以修复或修复它被称为组织再生。先天性疾病、异常和疾病引起的组织损伤都增加了组织再生的需要。组织工程是一种保存、恢复和改善受损组织功能的技术。组织再生过程通过重建受损器官来延长患者的预期寿命。

报告范围和市场细分

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制至 2019 - 2014)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

按技术(细胞疗法、干细胞疗法、干细胞来源、组织血管化、细胞培养等)、原材料(合成、转基因、生物)、应用(心血管、肿瘤学、皮肤病学、骨科、神经病学、眼科学等)、最终用户(医院和诊断中心、制药和生物技术公司、合同研究组织等)分类

覆盖国家

德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区

涵盖的市场参与者

Arteriocyte Medical Systems Inc. (U.S.), Athersys Inc. (Ohio), Cerapedics Inc. (U.S.), Co. Don AG (Germany), Cook Medical Inc. (U.S.), U.S. Stem Cell Inc. (U.S.), Cytori Therapeutics, Inc. (U.S.A), Cerapedicsm, Inc. (U.S.), Organogenesis, Inc. (U.S.), Wright Medical Group N.V. (Netherlands), Zimmer Biomet (US), ACell, Inc. (U.S.), Tissue Regenix (U.S.)

Market Opportunities

  • Growth in demand for technologies such as 3D printing
  • Increase in R&D activities

Tissue Regeneration Market Dynamics

Drivers

  • Increasing frequency of chronic diseases and the need for surgeries

The market is expected to grow during the projected period due to the increased use of biomarkers for illness detection and the rapid development of procedures such as stem cell technologies and gene therapy, among others. Increased responsiveness of the benefits and availability of equipment among doctors and convicts will also help to boost the tissue regeneration market's growth pace. The rising demand for tailored treatments will be a significant market driver, boosting the demand for tissue regeneration even more. In addition, changing lifestyles and eating habits will increase the risk of chronic diseases, resulting in a faster market growth rate.

  • Rising of the functions of 3D printing in tissue regeneration

 In the projected term, advancements in biomaterials, nanotechnology, cell treatments, and medication delivery are expected to boost the tissue regeneration market's growth. Government regulations, repayment concerns, particularly in emerging economies, in developing countries, are most likely to drive the tissue regeneration market's expansion.

  • Increase in popularity of tissue regeneration technology

The number of procedures for regeneration is on the rise. The use of tissue-engineered vascular grafts in the treatment and surgery of cardiovascular disease is being researched at the pre-clinical stage. Progress is currently being made in developing tissue-engineered bladders outside of the patient's body and successful transplantation.

Opportunities

During the forecast period, growth in demand for technologies such as 3D printing in tissue regeneration and an increase in R&D activities will provide new opportunities for the tissue regeneration market. Furthermore, government grants and investments and innovations in biomaterials, nanotechnology, cell treatments, and medication delivery are likely to improve the market's positive potential in the future.

Restraints/Challenges

However, the Europe market is likely to be hampered by tight government regulations, high treatment costs, and difficulty obtaining reimbursements and coverage for these therapies. This technique is costly (especially long-term choices), may have adverse effects on first-time patients, may lead to complications and even infections/ruptures in the early stages.

本组织再生市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关组织再生市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

COVID-19 对组织再生市场的影响

COVID-19 疫情对医疗保健行业产生了重大影响。自 COVID 19 疫情以来,临床组织工程研究已无法进行,非 COVID 19 临床试验也已减少。与此同时,许多制药和生物技术公司已将重点转向 COVID-19 治疗药物和疫苗。此外,细胞和组织捐赠计划的大幅减少限制了全球组织工程市场。因此,临床研究的延迟和干扰以及组织替换和重建治疗的取消或延迟阻碍了欧洲组织工程市场的增长。

近期发展

 2020年,美国卫生部宣布了“新视野”项目,旨在将再生医学和干细胞治疗推向医疗保健的前沿。

2020 年 4 月,组织再生技术公司 (TRT) 宣布其专利家族新增一项重要专利,该专利或将助力抗击冠状病毒。该专利利用众所周知的非聚焦冲击波过程来对抗这种致命病原体。

欧洲组织再生市场范围

组织再生市场根据成分、原材料、应用和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

成分

  • 细胞疗法
  • 干细胞治疗
  • 干细胞来源
  • 现有及开发阶段的干细胞产品
  • 组织血管化
  • 细胞培养
  • 小分子和生物制剂
  • 其他的

原料

  • 合成的
  • 转基因
  • 生物

应用

  • 心血管疾病
  • 肿瘤学
  • 皮肤科
  • 神经病学
  • 眼科
  • 其他的

终端用户

  • 医院
  • 诊所
  • 流动中心
  • 实验室

组织再生市场区域分析/见解

对组织再生市场进行了分析,并按国家、组件、原材料、应用和最终用户提供了市场规模洞察和趋势。

组织再生市场报告涵盖的国家包括德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其和欧洲其他地区。

在预测期内,欧洲预计将占据欧洲组织再生市场的大部分份额。在预测期内,新产品的发布、专注于研发的知名市场参与者以及慢性病发病率的上升预计将推动该地区组织再生市场的发展。

由于老年人口的增加,亚太地区的组织再生市场在预测期内可能会快速增长。此外,政府扩大医疗保健基础设施的努力预计将促进该地区的行业发展。

 报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

组织再生市场还为您提供每个国家/地区资本设备医疗支出增长、组织再生市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对组织再生市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。

竞争格局和组织再生市场份额分析

组织再生市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、欧洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对组织再生市场的关注有关。

组织再生市场的一些主要参与者包括:

  • Arteriocyte Medical Systems Inc.(美国)
  • Athersys Inc.(俄亥俄州)
  • Cerapedics Inc.(美国)
  • Co. Don AG(德国)
  • 库克医疗公司(美国)
  • 美国干细胞公司(美国)
  • Cytori Therapeutics, Inc.(美国)
  • Cerapedicsm, Inc.(美国)
  • Organogenesis, Inc.(美国)
  • Wright Medical Group NV(荷兰)
  • Zimmer Biomet(美国)
  • ACell, Inc.(美国)
  • Tissue Regenix(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The major players operating in the Europe Tissue Regeneration Market are Arteriocyte Medical Systems Inc. (U.S.), Athersys Inc. (Ohio), Cerapedics Inc. (U.S.), Co. Don AG (Germany), Cook Medical Inc. (U.S.), U.S. Stem Cell Inc. (U.S.), Cytori Therapeutics, Inc. (U.S.A), Cerapedicsm, Inc. (U.S.), Organogenesis, Inc. (U.S.), Wright Medical Group N.V. (Netherlands), Zimmer Biomet (US), ACell, Inc. (U.S.), Tissue Regenix (U.S.).
The major countries covered in the Europe Tissue Regeneration Market are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.